BÜHLMANN Laboratories AG participates at the upcoming Arab Health in Dubai, 25 - 28 January 2010 (http://www.arabhealthonline.com), together with its distributor for the Middle East, Bioactiva Diagnostica.

This participation is a unique chance to get first hand information and support for BÜHLMANN Products. We invite customers to visit us at the Bioactiva Diagnostics Booth in the Sheik Maktoum Hall, booth MF 31, or even better to fix an appointment (info@buhlmannlabs.ch).

BÜHLMANN will be represented with its COO, Dr. Thomas Hafen. We are looking forward to be in contact with current and prospective customers and to highlight some of our products like Calprotectin. We are however also interested to get in contact with new distributors serving some of the rapidly growing markets on the African or Asian continent.

BÜHLMANN Laboratories AG is proud to introduce its latest sister company BUHLMANN Italia srl, to go live on January 1^st, 2010. The new company will serve all of the BÜHLMANN customers in Italy and significantly strengthen the presence of BÜHLMANN in the Italian market.

Dr.ssa Daniela Maioli, Director Marketing&Sales of BUHLMANN Italia srl: "The new company allows us to be even closer to our customers and to serve them better. BÜHLMANN has excellently developed in Italy in the last years and more and more hospitals and laboratories request the BÜHLMANN high quality products. That BÜHLMANN Laboratories AG have decided to start an own company in Italy reflects the importance of this market and of our customers."

Thomas Hafen, COO of BÜHLMANN Laboratories AG: "Italian customers are known as very experienced, professional and innovative. They are always looking for new, quality products and innovations - attributes BÜHLMANN stands for. BUHLMANN Italia srl is our chance to use this potential even better. Beyond this, BUHLMANN Italia srl strengthens our position as a leading niche supplier of clinical routine diagnostics and high quality distributor of IVDs in immunochemistry and molecular diagnostics."

BÜHLMANN Laboratories AG was founded in 1976 in Basel / Switzerland. BUHLMANN Italia srl is the third BÜHLMANN sister company, after BÜHLMANN in Austria GmbH (1992) and BÜHLMANN France SAS (2002). Together with BÜHLMANN Germany, the BÜHLMANN Group now covers up to 70% of the European IVD Market with direct sales channels to laboratories and hospitals.

BÜHLMANN is specialised in high quality niches of clinical routine IVDs, and offers a number of unique or gold standard products to the market. Product range includes leading cellular allergy test Flow2 CAST^®, the BÜHLMANN GanglioCombi^® Product group or the gold standard Melatonin products. Recent releases are a unique Parkinson MeTIQ ELISA or the fastest and easiest GHB Drug of Abuse tests (“k.o. drops”) for open channels of clinical chemistry analyzers. For Calprotectin, BÜHLMANN cooperates in Italy with Meridian Biosciences Europe srl, Milan, namely for the promotion of Quantum Blue^® Calprotectin - the only quantitative rapid Calprotectin test so far available on the market.

In collaboration with the Basel University of Applied Life Sciences (Fachhochschule Nordwestschweiz) we developed in the field of Neurology / NeuroImmunology and in vitro diagnostics: Parkinson-MeTIQ ELISA  it is designed for the quantitative determination of 1-MeTIQ (1-Methyl-1,2,3,4-Tetrahydroisoquinoline) and it’s meant to be measured in patients and animal models with Parkinson Disease (PD).